{"id":155645,"date":"2025-06-06T04:40:18","date_gmt":"2025-06-06T04:40:18","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/155645\/"},"modified":"2025-06-06T04:40:18","modified_gmt":"2025-06-06T04:40:18","slug":"et-si-les-nouveaux-traitements-permettaient-deviter-la-chirurgie-contre-les-tumeurs-pulmonaires","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/155645\/","title":{"rendered":"Et si les nouveaux traitements permettaient d\u2019\u00e9viter la chirurgie contre les tumeurs pulmonaires\u00a0?"},"content":{"rendered":"

D\u00c9CRYPTAGE<\/strong> – Un quart des patients qui re\u00e7oivent le traitement n\u2019ont plus de cellules canc\u00e9reuses dans leur tumeur lorsqu\u2019ils sont op\u00e9r\u00e9s par la suite.<\/p>\n

Avec 1,8\u00a0million de d\u00e9c\u00e8s par an dans le monde, le\u00a0cancer des poumons<\/a>\u00a0est celui qui fait le plus de victimes. En France, on compte environ 50.000 nouveaux malades par an, ce qui en fait est le troisi\u00e8me cancer en nombre de cas. Plusieurs \u00e9tudes pr\u00e9sent\u00e9es cette ann\u00e9e au congr\u00e8s annuel de la soci\u00e9t\u00e9 am\u00e9ricaine d\u2019oncologie (Asco) \u00e0 Chicago ont apport\u00e9 de r\u00e9els motifs d\u2019espoir. Parmi elles, l\u2019\u00e9tude CheckMate-816, coordonn\u00e9e par le professeur Nicolas Girard, pneumologue, chef du d\u00e9partement d\u2019oncologie m\u00e9dicale \u00e0 l\u2019Institut Curie<\/a>. Elle concerne la forme la plus fr\u00e9quente de cancer du poumon, celle dite non \u00e0 petites cellules. Les r\u00e9sultats ont \u00e9t\u00e9 \u00e9galement publi\u00e9s dans la revue New England Journal of Medicine.<\/p>\n

Quand ces cancers sont diagnostiqu\u00e9s suffisamment t\u00f4t, la chirurgie est assez efficace. Mais si le pronostic vital est alors plut\u00f4t bon, le risque de rechute demeure \u00e9lev\u00e9. \u00ab\u00a0Plus la tumeur est grosse, plus le risque est fort, explique Nicolas Girard. Pour une tumeur d\u2019un centim\u00e8tre\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 82% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vente Flash<\/p>\n

3,99\u20ac par mois pendant 12 mois. Sans engagement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"D\u00c9CRYPTAGE – Un quart des patients qui re\u00e7oivent le traitement n\u2019ont plus de cellules canc\u00e9reuses dans leur tumeur…\n","protected":false},"author":2,"featured_media":155646,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[237,101,232,231,234,228,1011,27,72,239,230,238,226,224,225,233,229,236,235,71,227],"class_list":{"0":"post-155645","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-fr","15":"tag-france","16":"tag-health","17":"tag-info-sur-les-maladies","18":"tag-infographie","19":"tag-information-sur-les-maladies","20":"tag-maladie","21":"tag-medecine","22":"tag-medicament","23":"tag-obesite","24":"tag-pathologie","25":"tag-pediatrie","26":"tag-psychiatrie","27":"tag-sante","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114634583385923608","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/155645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=155645"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/155645\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/155646"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=155645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=155645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=155645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}